Circulating Tumor Cells Enumerated by a Centrifugal Microfluidic Device as a Predictive Marker for Monitoring Ovarian Cancer Treatment: A Pilot Study
Open Access
- 23 April 2020
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 10 (4) , 249
Abstract
We investigated the size-based isolation and enumeration of circulating tumor cells (CTCs) using a centrifugal microfluidic device equipped with a fluid-assisted separation technology (FAST) disc. We further assessed the correlations among CTCs, cancer antigen-125 (CA125) levels, and clinical course of the disease in a prospective analysis of 47 serial blood samples collected at multiple time-points from 13 ovarian cancer patients. CTCs were isolated from whole blood using the FAST disc and were classified as epithelial cell adhesion molecule (EpCAM)/cytokeratin+, CD45−, and 4′,6-diamidino-2-phenylindole (DAPI)+. Mean CTC count at baseline was 20.2; 84.62% of patients had more than one CTC at baseline and had decreased CTCs counts after surgery and chemotherapy. The CTC counts in eight patients with complete responses were <3. CTC counts were correlated with CA125 levels in three patients without recurrence; they were elevated in three patients with recurrence and normal CA125 concentrations. CTC counts and CA125 levels showed high concordance with directional changes (increasing 71.4%; non-increasing 75.0%). CTC counts showed higher associations with clinical status, sensitivity (100.0% vs. 60.0%), positive predictive value (55.6% vs. 42.9%), and negative predictive value (100.0% vs. 87.5%) than CA125 levels. CTC counts were better associated with treatment response and recurrence than CA125 levels.Keywords
Funding Information
- Korean government (IBS-R020-D1)
- Ministry of Health & Welfare, Republic of Korea (A121994)
This publication has 42 references indexed in Scilit:
- Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNAClinical Chemistry and Laboratory Medicine (CCLM), 2017
- Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast CancerClinical Cancer Research, 2016
- Clinical and biological significance of circulating tumor cells in cancerMolecular Oncology, 2016
- Importance of circulating tumor cells in newly diagnosed colorectal cancerInternational Journal of Oncology, 2015
- Ten-Year Relative Survival for Epithelial Ovarian CancerObstetrics & Gynecology, 2012
- Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancerGynecologic Oncology, 2009
- The role of CA125 in clinical practiceJournal of Clinical Pathology, 2005
- Use of CA-125 in Clinical Trial Evaluation of New Therapeutic Drugs for Ovarian CancerClinical Cancer Research, 2004
- Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer☆Gynecologic Oncology, 2003
- Benign conditions associated with raised serum CA-125 concentrationJournal of Surgical Oncology, 2000